The data on the first 1000 health professionals, vaccinated on December 2020, reveals that 90% developed antibodies in the three weeks following the administration of the first dose. The study, carried out by Instituto Gulbenkian de Ciência (IGC) and Centro Hospitalar de Lisboa Ocidental, E.P.E. (CHLO), intends to evaluate the effectiveness of the vaccine and the response to different variants, in a range of 1200 health professionals, vaccinated with the first vaccine available nationwide. This data collection has been recommended by the World Health Organization to monitor the introduction of the new vaccine internationally.
Check the latest news in the press about this initiative (in Portuguese):
in SIC Notícias